CSE: MDM FSE: 2Mo OTCQB: MRPHF
KELOWNA, BC, Nov. 21, 2017 /CNW/ - Marapharm Ventures Inc., "Marapharm", announced the launch of daily programming featuring news and market reports about cannabis and the cannabis industry. The station is designed for the interested public, shareholders, and the industry, to keep up with the latest news and information and can be found at www.marapharm.tv.
"People want to be informed about marijuana with reputable news and information. At Marapharm.tv, we draw from verified sources to provide visitors with a comprehensive roundup of the latest news reports on health, education, legislation, and business. We combine industry related news with a weekly market report on trading activities and share prices to keep viewers informed of the most recent business news and factors that could affect stock prices."
The goal is to provide visitors with one convenient site where they can access all the information they need while creating awareness about the marijuana sector, in addition to Marapharm's operations and stock.
"The online division operates independently from Marapharm's cannabis operations. We are in the process of expanding operations and developing a new line of programming that will include interviews with high profile leaders in business and politics. Viewers are increasing at a fast pace as they find Marapharm.tv to be a reputable online source where they can access all the latest marijuana news in one location." Henrietta Poirier, Director of Communications, Marapharm.tv.
ABOUT MARAPHARM VENTURES INC.
Marapharm is a publicly traded company primarily investing in the medical and recreational cannabis space, with corporate operations based in British Columbia, Canada. Since 2016 they have rapidly expanded their footprint to include production locations in the key North American states of Washington, Nevada, and California. They actively seek expansion opportunities worldwide.
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQB, and in Europe, ticker symbol 2Mo on the FSE. Marapharm also trades on other recognized platforms in Europe including Stuttgart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.
Neither the CSE, the FSE nor the OTCQB® has approved nor disapproved the contents of this press release. Neither the CSE, the FSE nor the OTCQB® accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required by regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicable state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change.
Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Marapharm's ability to access private and public capital could be affected and or could not be available to support continuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance with licensing requirements.
Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has compliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and state law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance in Canada and the US.
FORWARD - LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements are based on reasonable assumption but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.
SOURCE Marapharm Ventures Inc.
For further information: www.marapharm.com or Linda Sampson, CEO 778-583-4476, email firstname.lastname@example.org